Risk Factors for Progression of Age-Related Macular Degeneration: Population-Based Amish Eye Study

Area of Science:

• Ophthalmology
• Medical Imaging
• Gerontology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly.
• Optical coherence tomography (OCT) provides detailed cross-sectional imaging of the retina.
• Identifying early risk factors for AMD progression is crucial for timely intervention.

Purpose of the Study:

• To assess optical coherence tomography (OCT)-based risk factors for progression to late age-related macular degeneration (AMD).
• To evaluate these risk factors in a population-based cohort of elderly Amish individuals.
• To correlate specific OCT imaging features with the 2-year incidence of late AMD.

Main Methods:

• A prospective, longitudinal, observational study included 1332 eyes from 666 elderly Amish subjects with a 2-year follow-up.
• Baseline OCT images were analyzed for drusen volume (≥0.03 mm³ in the central 3 mm ring), intraretinal hyperreflective foci (IHRF), hyporeflective drusen cores (hDC), subretinal drusenoid deposits (SDD), and drusenoid pigment epithelium detachment (PED).
• Logistic regression models were used to estimate odds ratios for imaging features associated with late AMD development.

Main Results:

• Of 1332 eyes, 21 (1.5%) progressed to late AMD within 2 years.
• Univariate analysis showed significant associations between increased late AMD risk and drusen area/volume, subfoveal choroidal thickness, SDD, IHRF, and hDC.
• Multivariate regression identified high central drusen volume (OR: 2.59, p=0.049) and the presence of IHRF (OR: 57.06, p<0.001) as independent predictors of late AMD progression.

Conclusions:

• This study confirms that high central drusen volume and intraretinal hyperreflective foci (IHRF) are significant risk factors for progression to late age-related macular degeneration (AMD).
• These OCT findings are valuable for risk-stratifying patients in clinical settings.
• Identifying individuals at high risk can facilitate recruitment for early intervention clinical trials.